Invention Grant
- Patent Title: Compositions and methods for inhibition of the JAK pathway
-
Application No.: US15637833Application Date: 2017-06-29
-
Publication No.: US10421752B2Publication Date: 2019-09-24
- Inventor: Hui Li , Sambaiah Thota , David Carroll , Ankush Argade , Kin Tso , Arvinder Sran , Jeffrey Clough , Holger Keim , Somasekhar Bhamidipati , Vanessa Taylor , Robin Cooper , Rajinder Singh , Brian Wong
- Applicant: Rigel Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Klarquist Sparkman, LLP
- Agent Travis Young
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D413/12 ; C07D403/04 ; C07D239/42 ; C07D239/48 ; C07D401/12 ; C07D403/12 ; C07D413/14 ; A61K31/343 ; A61K31/436 ; A61K31/505 ; A61K31/5377 ; A61K31/538 ; A61K31/5383 ; A61K31/541 ; A61K31/695 ; A61K38/13 ; A61K39/395 ; C07D498/04 ; C07F7/10 ; A61K45/06 ; C07D401/14 ; C07D417/12 ; C07F7/08 ; C07D285/22
Abstract:
The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.
Public/Granted literature
- US20170298054A1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Public/Granted day:2017-10-19
Information query
IPC分类:
